المؤلفون: Remy Klaassen, Oliver J. Gurney-Champion, Marie Cecile J.C. Legdeur, Marjolein C. H. Pleunis-van Empel, Hanneke W. M. van Laarhoven, Johanna W. Wilmink, Koen S. van der Lee, Aart J. Nederveen, Esther N. Pijnappel, Dick J. Richel, Nienke P. M. Wassenaar

المساهمون: CCA - Cancer Treatment and Quality of Life, Graduate School, Oncology, Radiology and Nuclear Medicine, Anesthesiology, ACS - Diabetes & metabolism, AMS - Ageing & Vitality, AMS - Sports, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Cancers
Volume 13
Issue 19
Cancers, 13(19):4869. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 4869, p 4869 (2021)

مصطلحات موضوعية: Target lesion, Oncology, metastatic pancreatic ductal adenocarcinoma, medicine.medical_specialty, Cancer Research, Hedgehog signaling pathway inhibitor, FOLFIRINOX, medicine.medical_treatment, quantitative MRI, Article, Stoma (medicine), Internal medicine, Metastatic pancreatic cancer, Medicine, In patient, RC254-282, Nab-paclitaxel, Chemotherapy, Tumor microenvironment, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, pancreatic neoplasms, medicine.disease, Gemcitabine, Desmoplasia, Phase i ii, LDE225, Cancer research, medicine.symptom, business, Perfusion, Progressive disease, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29658cb32aaf5f68c2443f3da0f5aad

المؤلفون: Peter J. M. Valk, Yves Chalandon, Thomas Pabst, Markus G. Manz, Dimitri Breems, Maaike Sohne, Bob Löwenberg, Emanuele Ammatuna, Marjolein van der Poel, Sabine Blum, Dries Deeren, Rien van Marwijk Kooy, Dana A. Chitu, Mojca Jongen-Lavrencic, Lidwine W. Tick, Marie Cecile J.C. Legdeur, Gerwin Huls, Saskia K. Klein, Danielle van Lammeren-Venema, Gert J. Ossenkoppele, Georg Stussi, Arjan A. van de Loosdrecht, Isabelle A van Zeventer, Rinske S. Boersma, M. Fehr, Mels Hoogendoorn, Jacqueline Cloos, Laimonas Griskevicius

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Hematology laboratory, CCA - Cancer Treatment and quality of life, Hematology, University of Zurich, Huls, Gerwin, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Blood advances, vol. 4, no. 18, pp. 4267-4277
Blood Advances, Vol. 4, No 18 (2020) pp. 4267-4277
Blood, 4(18), 4267-4277. AMER SOC HEMATOLOGY
Blood, 4(18), 4267-4277. American Society of Hematology
Blood advances, 4(18), 4267-4277. American Society of Hematology
Huls, G, Chitu, D A, Pabst, T, Klein, S K, Stussi, G, Griskevicius, L, Valk, P J M, Cloos, J, van de Loosdrecht, A A, Breems, D, van Lammeren-Venema, D, van Zeventer, I, Boersma, R, Jongen-Lavrencic, M, Fehr, M, Hoogendoorn, M, Manz, M G, Söhne, M, Kooy, R V M, Deeren, D, van der Poel, M W M, Legdeur, M C, Tick, L, Chalandon, Y, Ammatuna, E, Blum, S, Löwenberg, B & Ossenkoppele, G J 2020, ' Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS ', Blood, vol. 4, no. 18, pp. 4267-4277 . https://doi.org/10.1182/BLOODADVANCES.2020002846
Blood advances, 4(18), 4267-4277. The American Society of Hematology
Blood Adv

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Clinical Trials and Observations, medicine.medical_treatment, 2720 Hematology, Decitabine, MINIMAL RESIDUAL DISEASE, 610 Medicine & health, Hematopoietic stem cell transplantation, ACUTE MYELOID-LEUKEMIA, chemistry.chemical_compound, Piperidines, Internal medicine, CONVENTIONAL CARE REGIMENS, AZACITIDINE THERAPY, Humans, Medicine, Adverse effect, TREATMENT RESPONSE, Netherlands, MYELODYSPLASTIC SYNDROME, ddc:616, business.industry, Adenine, CLINICAL-RESPONSE, Myeloid leukemia, Hematology, Minimal residual disease, Transplantation, Leukemia, Myeloid, Acute, chemistry, Tolerability, HYPOMETHYLATING AGENT THERAPY, Myelodysplastic Syndromes, Ibrutinib, 10032 Clinic for Oncology and Hematology, SURVIVAL, TRIAL, business, medicine.drug

وصف الملف: application/pdf; advancesadv2020002846.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f035f8641df261cae7346abf960dbaaf
https://serval.unil.ch/notice/serval:BIB_BA95A00DDE07

المؤلفون: Petra Muus, Pedro da Silva-Coelho, Theresia M. Westers, Edo Vellenga, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Joop H. Jansen, Canan Alhan, Georgina E. de Greef, Vincent H.J. van der Velden, Jeroen G. te Marvelde, Eline M. P. Cremers, Saskia K. Klein, Marie Cecile J.C. Legdeur, Claudia Cali, Pierre W. Wijermans, Marian Stevens-Kroef, Dana A. Chitu, Heleen Visser-Wisselaar

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL), Hematology, Immunology, Hematology laboratory, CCA - Imaging and biomarkers, AGEM - Digestive immunity, Internal medicine

المصدر: Haematologica, 102, 2, pp. 320-326
Haematologica, 102, 320-326
Haematologica, 102(2), 320-326. FERRATA STORTI FOUNDATION
Cremers, E M P, Westers, T M, Alhan, C, Cali, C, Visser-Wisselaar, H A, Chitu, D A, van der Velden, V H J, te Marvelde, J G, Klein, S K, Muus, P, Vellenga, E, de Greef, G E, Legdeur, M C C J C, Wijermans, P W, Stevens-Kroef, M J P L, da Silva-Coelho, P, Jansen, J H, Ossenkoppele, G J, van de Loosdrecht, A A & HOVON89 study group 2017, ' Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes ', Haematologica, vol. 102, no. 2, pp. 320-326 . https://doi.org/10.3324/haematol.2016.147843
Haematologica, 102(2), 320-326. Ferrata Storti Foundation

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pathology, Lineage (genetic), BONE-MARROW, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], WORLD-HEALTH-ORGANIZATION, CLASSIFICATION, VALIDATION, Flow cytometry, Immunophenotyping, 03 medical and health sciences, 0302 clinical medicine, Erythroid Cells, EUROPEAN LEUKEMIANET, Internal medicine, medicine, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Humans, Cell Lineage, DYSPLASIA, INTERNATIONAL CONSORTIUM, MYELOID NEOPLASMS, Aged, Aged, 80 and over, UTILITY, Hematology, medicine.diagnostic_test, business.industry, Myelodysplastic syndromes, Articles, LEUKEMIANET WORKING GROUP, Middle Aged, medicine.disease, Flow Cytometry, medicine.anatomical_structure, Dysplasia, 030220 oncology & carcinogenesis, Case-Control Studies, Myelodysplastic Syndromes, Female, Bone marrow, business, Biomarkers, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665c4035e407077a251915bdbf2a9a76
https://hdl.handle.net/2066/169708

المؤلفون: Versluis J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kalin B; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Zeijlemaker W; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Passweg J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Graux C; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Manz MG; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Vekemans MC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Biemond BJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Legdeur MJC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kooy MVM; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., de Weerdt O; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Wijermans PW; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Hoogendoorn M; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Bargetzi MJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Kuball J; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Schouten HC; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., van der Velden VHJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Janssen JJWM; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Pabst T; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Lowenberg B; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Jongen-Lavrencic M; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Schuurhuis GJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Ossenkoppele G; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Cornelissen JJ; Jurjen Versluis, Burak Kalin, Bob Lowenberg, Mojca Jongen-Lavrencic, and Jan J. Cornelissen, Erasmus University Medical Center Cancer Institute; Vincent H.J. van der Velden, Erasmus University Medical Center, Rotterdam; Wendelien Zeijlemaker, Jeroen J.W.M. Janssen, Gerrit Jan Schuurhuis, and Gert Ossenkoppele, VU University Medical Center; Bart J. Biemond, Academic Medical Center, University of Amsterdam, Amsterdam; Marie-Cecile J.C. Legdeur, Medisch Spectrum Twente, Enschede; Marinus van Marwijk Kooy, Isala Hospital, Zwolle; Okke de Weerdt, Antonius Hospital, Nieuwegein; Pierre W. Wijermans, Haga Hospital, The Hague; Mels Hoogendoorn, Medical Center Leeuwarden, Leeuwarden; Juergen Kuball, University Medical Center Utrecht, Utrecht; Harry C. Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Jakob Passweg, University Hospital Basel, Basel; Markus G. Manz, University Hospital Zürich, Zürich; Mario J. Bargetzi, Kantonsspital Aarau, Aarau; Thomas Pabst, Inselspital, Bern University Hospital, Bern, Switzerland; Carlos Graux, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

المصدر: JCO precision oncology [JCO Precis Oncol] 2017 Nov; Vol. 1, pp. 1-13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE; MEDLINE